KaloBios Pharmaceuticals Inc. (Nasdaq: KBIO) chief executive Martin Shkreli tweeted that he would no longer lend stock to short sellers. The stock price leaped $8.20 to close at $34.83.
KaloBios CEO ends loans to short sellers
November 27, 2015 at 14:41 PM EST